TP63 Gene Ectodactyly Ectodermal Dysplasia and Cleft Lippalate Syndrome Type 3 Genetic Test
Test Name: TP63 Gene Ectodactyly Ectodermal Dysplasia and Cleft Lippalate Syndrome Type 3 Genetic Test
Components: DNA Labs UAE
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for TP63 Gene Ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TP63 Gene Ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3 NGS Genetic DNA Test gene TP63
Test Details: The TP63 gene is associated with a variety of genetic disorders, including ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3. Ectodactyly is a condition characterized by the absence or malformation of one or more fingers or toes. Ectodermal dysplasia refers to a group of conditions that affect the development of ectodermal structures, such as hair, teeth, nails, and sweat glands. Cleft lip and/or palate is a facial malformation where the lip and/or roof of the mouth do not form properly. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the context of TP63 gene-related disorders, NGS genetic testing can identify mutations or variants in the TP63 gene that may be responsible for the individual’s symptoms. By performing NGS genetic testing, healthcare professionals can confirm a diagnosis of ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3 and provide appropriate management and counseling for affected individuals and their families.
Test Name | TP63 Gene Ectodactyly ectodermal dysplasia and cleft lippalate syndrome type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TP63 Gene Ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TP63 Gene Ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3 NGS Genetic DNA Test gene TP63 |
Test Details |
The TP63 gene is associated with a variety of genetic disorders, including ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3. Ectodactyly is a condition characterized by the absence or malformation of one or more fingers or toes. Ectodermal dysplasia refers to a group of conditions that affect the development of ectodermal structures, such as hair, teeth, nails, and sweat glands. Cleft lip and/or palate is a facial malformation where the lip and/or roof of the mouth do not form properly. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the context of TP63 gene-related disorders, NGS genetic testing can identify mutations or variants in the TP63 gene that may be responsible for the individual’s symptoms. By performing NGS genetic testing, healthcare professionals can confirm a diagnosis of ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3 and provide appropriate management and counseling for affected individuals and their families. |